Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125253072 | 12525307 | 2 | F | 20160329 | 20160627 | 20160704 | 20160830 | EXP | JP-ASTRAZENECA-2016SE71426 | ASTRAZENECA | 72.00 | YR | F | Y | 52.00000 | KG | 20160831 | PH | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125253072 | 12525307 | 1 | PS | IRESSA | GEFITINIB | 1 | Oral | 31500 | MG | N | U | 206995 | 250 | MG | TABLET | QD | |||
| 125253072 | 12525307 | 2 | C | ETIZOLAM | ETIZOLAM | 1 | Unknown | 0 | .5 | MG | QD | ||||||||
| 125253072 | 12525307 | 3 | C | FAMOTIDINE. | FAMOTIDINE | 1 | Unknown | 0 | 20 | MG | BID | ||||||||
| 125253072 | 12525307 | 4 | C | SENNOSIDE | SENNOSIDES | 1 | Unknown | 0 | 12 | MG | QD | ||||||||
| 125253072 | 12525307 | 5 | C | MAGMITT | MAGNESIUM OXIDE | 1 | Unknown | 0 | 330 | MG | TID | ||||||||
| 125253072 | 12525307 | 6 | C | MS-TWICELON | 2 | Oral | 0 | 10 | MG | CAPSULE | BID | ||||||||
| 125253072 | 12525307 | 7 | C | OPSO | MORPHINE HYDROCHLORIDE | 1 | Unknown | NUMBER OF SEPARATE DOSAGES UNKNOWN | 0 | 5 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125253072 | 12525307 | 1 | Lung adenocarcinoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125253072 | 12525307 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125253072 | 12525307 | Decreased appetite | |
| 125253072 | 12525307 | Eczema | |
| 125253072 | 12525307 | Excessive granulation tissue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125253072 | 12525307 | 1 | 20160120 | 20160524 | 0 |